BIVI stock news · BioVie Inc.
Get alerts for BIVI
Follow BioVie Inc. (BIVI) free. When we publish a story about it, you get the plain-English explanation as an alert.
Get alerts for BIVIFree on the App Store and Google Play, or on the web.
BioVie is set to raise about $4.74 million through a direct sale and private placement.
NeutralBioVie agreed to sell 2,962,500 shares or equivalents at $1.60 each, raising about $4.74 million before costs. Cash helps, but added shares weigh against it, leaving the story balanced.
On Tuesday, 12 health care stocks saw big price changes during the day.
NeutralBioVie shares fell about 8%, but the article gives no business update or reason for the move. The share-price change alone does not alter the company's outlook.
BioVie stock drops 16.10% to $1.72 after mixed results from a key study.
NeutralBioVie’s Phase 2 missed statistical significance in the full group, yet pre-specified subgroups (about 78%) showed benefit; I read this as neutral until a prospective confirmatory study.